Get started
Author

Michaela A. Onstad

Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
2016 · Michaela A. Onstad, Rosemarie E. Schmandt, et al. · Journal of Clinical Oncology · 643
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
2023 · Shannon N. Westin, Kathleen Moore, et al. · Journal of Clinical Oncology · 381
PDF
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
2023 · Ana Oaknin, Ana Oaknin, et al. · The Lancet · 240
Benign Breast Disorders
2013 · Michaela Onstad, Ashley Stuckey · Obstetrics and Gynecology Clinics of North America · 100
ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment
2020 · Chi-Lam Au-Yeung, Tsz-Lun Yeung, et al. · Nature Communications · 63
PDF
Breast-Specific Sensuality and Sexual Function in Cancer Survivorship: Does Surgical Modality Matter?
2017 · Jennifer S. Gass, Michaela Onstad, et al. · Annals of Surgical Oncology · 56
Hereditary breast cancer: an update on risk assessment and genetic testing in 2015
2015 · Ashley R. Stuckey, Michaela A. Onstad · American Journal of Obstetrics and Gynecology · 42
Influential Forces in Breast Cancer Surgical Decision Making and the Impact on Body Image and Sexual Function
2016 · Rebecca M. Kwait, Sarah Pesek, et al. · Annals of Surgical Oncology · 39
Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship
2017 · K. E. Rojas, N. Matthews, et al. · Journal of Cancer Survivorship · 36
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition
2017 · Kari L. Ring, Melinda S. Yates, et al. · International Journal of Gynecological Cancer · 30
The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance, and the reconstructed breast’s role in intimacy
2017 · K. Rojas, M. Onstad, et al. · Breast Cancer Research and Treatment · 27
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
2017 · Michaela A. Onstad, Rosemarie E. Schmandt, et al. · Obstetrical & Gynecological Survey · 26
Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma
2021 · Duygu Sezen, Roshal R. Patel, et al. · Gynecologic Oncology · 22
PDF
Movement of Poly-ADP Ribose (PARP) Inhibition into Frontline Treatment of Ovarian Cancer
2020 · Michaela Onstad, Robert L. Coleman, et al. · Drugs · 13
Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer
2020 · Nicole D Fleming, Shannon N Westin, et al. · International Journal of Gynecological Cancer · 9
PDF
Phase II trial of MEDI0457 and durvalumab for patients with recurrent/metastatic HPV-associated cancers.
2021 · Van K. Morris, Amir A. Jazaeri, et al. · Journal of Clinical Oncology · 8
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus
2020 · Michaela Onstad, Jennifer Ducie, et al. · International Journal of Gynecological Cancer · 7
Serum omentin concentration is a potential biomarker for complex atypical hyperplasia and endometrioid endometrial cancer
2014 · L.L. Holman, M. Onstad, et al. · Gynecologic Oncology · 7
Sexual Function After Breast Cancer Surgery
2015 · S. Pesek, M. Onstad, et al. · Gynecologic Oncology · 5
A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs
2020 · Emily Hinchcliff, Jillian Gunther, et al. · Journal of Cancer Education · 4
Adjuvant therapy for grade 3, deeply invasive endometrioid adenocarcinoma of the uterus
2016 · M. Onstad, J.A. Ducie, et al. · Gynecologic Oncology · 1
PDF
Omentin as a potential biomarker related to exercise and cancer risk.
2015 · Michaela Onstad, Karen Basen-Engquist, et al. · Journal of Clinical Oncology · 1
Omentin as a biomarker associated with improved overall survival in serous ovarian cancer.
2015 · Michaela Onstad, Laura L. Holman, et al. · Journal of Clinical Oncology · 1
Omentin as a biomarker associated with improved overall survival in serous ovarian cancer
2015 · M. Onstad, L.L. Holman, et al. · Gynecologic Oncology · 1
Abstract 4887: Omentin: A novel adipokine in the omental microenvironment associated with ovarian cancer progression
2014 · Chi Lam Au Yeung, Ngai Na Co, et al. · Cancer Research · 1
Works count: 40
Citation count: 1,760
H-index: 13
I10-index: 14
Year
Topic
Type